These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 32273252)

  • 1. Protocol for a randomised controlled trial evaluating the impact of a community pharmacy discharge medication reconciliation service on unplanned hospital readmissions - The DCMedsRec trial.
    Duncan G; Ngo C; Fanning L; Taylor DA; McNamara K; Caliph S; Suen B; Johnston S; Darzins P
    Res Social Adm Pharm; 2021 Feb; 17(2):460-465. PubMed ID: 32273252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OPTimising MEDicine information handover after Discharge (OPTMED-D): protocol for development of a multifaceted intervention and stepped wedge cluster randomised controlled trial.
    Hattingh L; Baysari MT; Foot H; Sim TF; Keijzers G; Morgan M; Scott I; Norman R; Yong F; Mullan B; Jackson C; Oldfield LE; Manias E
    Trials; 2024 Sep; 25(1):632. PubMed ID: 39334438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using novel Canadian resources to improve medication reconciliation at discharge: study protocol for a randomized controlled trial.
    Tamblyn R; Huang AR; Meguerditchian AN; Winslade NE; Rochefort C; Forster A; Eguale T; Buckeridge D; Jacques A; Naicker K; Reidel KE
    Trials; 2012 Aug; 13():150. PubMed ID: 22920446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a pharmacist-led medication review on hospital readmission in a pediatric and elderly population: study protocol for a randomized open-label controlled trial.
    Renaudin P; Baumstarck K; Daumas A; Esteve MA; Gayet S; Auquier P; Tsimaratos M; Villani P; Honore S
    Trials; 2017 Feb; 18(1):65. PubMed ID: 28183322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inpatient pharmacists using a readmission risk model in supporting discharge medication reconciliation to reduce unplanned hospital readmissions: a quality improvement intervention.
    Gallagher D; Greenland M; Lindquist D; Sadolf L; Scully C; Knutsen K; Zhao C; Goldstein BA; Burgess L
    BMJ Open Qual; 2022 Mar; 11(1):. PubMed ID: 35241436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of drug reconciliation at discharge and communication between hospital and community pharmacists on drug-related problems: study protocol for a randomized controlled trial.
    Pourrat X; Roux C; Bouzige B; Garnier V; Develay A; Allenet B; Fraysse M; Halimi JM; Grassin J; Giraudeau B
    Trials; 2014 Jun; 15():260. PubMed ID: 24981605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist linkage in care transitions: From academic medical center to community.
    Bloodworth LS; Malinowski SS; Lirette ST; Ross LA
    J Am Pharm Assoc (2003); 2019; 59(6):896-904. PubMed ID: 31590926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review and meta-analysis.
    Mekonnen AB; McLachlan AJ; Brien JA
    J Clin Pharm Ther; 2016 Apr; 41(2):128-44. PubMed ID: 26913812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of clinical pharmacist engagement in ward teams on the number of drug-related readmissions among older patients with dementia or cognitive impairment: An economic evaluation.
    Sjölander M; Lindholm L; Pfister B; Jonsson J; Schneede J; Lövheim H; Gustafsson M
    Res Social Adm Pharm; 2019 Mar; 15(3):287-291. PubMed ID: 29778344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a Collaborative Protocolized Approach by Community Pharmacists and General Medical Practitioners for an Australian Minor Ailments Scheme: Protocol for a Cluster Randomized Controlled Trial.
    Dineen-Griffin S; Garcia-Cardenas V; Rogers K; Williams K; Benrimoj SI
    JMIR Res Protoc; 2019 Aug; 8(8):e13973. PubMed ID: 31400107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community pharmacy transition of care services and rural hospital readmissions: A case study.
    Patton AP; Liu Y; Hartwig DM; May JR; Moon J; Stoner SC; Guthrie KD
    J Am Pharm Assoc (2003); 2017; 57(3S):S252-S258.e3. PubMed ID: 28412054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis.
    Mekonnen AB; McLachlan AJ; Brien JA
    BMJ Open; 2016 Feb; 6(2):e010003. PubMed ID: 26908524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving care transitions through medication therapy management: A community partnership to reduce readmissions in multiple health-systems.
    Heaton PC; Frede S; Kordahi A; Lowery L; Moorhead B; Kirby J; Kunze N; Luder H
    J Am Pharm Assoc (2003); 2019; 59(3):319-328. PubMed ID: 30819640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study.
    Stafford L; Peterson GM; Bereznicki LR; Jackson SL
    BMC Health Serv Res; 2011 Jan; 11():16. PubMed ID: 21261998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the population health inpatient Medicare Advantage pharmacist intervention on hospital readmissions: A quasi-experimental controlled study.
    Nguyen AT; Wisniewski J; Leang DW; Keller MS; Rosen S; Shane R; Pevnick JM
    J Manag Care Spec Pharm; 2023 Mar; 29(3):266-275. PubMed ID: 36840959
    [No Abstract]   [Full Text] [Related]  

  • 16. Exploring the association of the discharge medicines review with patient hospital readmissions through national routine data linkage in Wales: a retrospective cohort study.
    Mantzourani E; Nazar H; Phibben C; Pang J; John G; Evans A; Thomas H; Way C; Hodson K
    BMJ Open; 2020 Feb; 10(2):e033551. PubMed ID: 32041857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a pharmacist-driven intervention program on hospital readmissions.
    Shull MT; Braitman LE; Stites SD; DeLuca A; Hauser D
    Am J Health Syst Pharm; 2018 May; 75(9):e221-e230. PubMed ID: 29691265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of a multicomponent pharmacist intervention at hospital discharge for drug-related problems: A cluster randomised cross-over trial.
    Pourrat X; Leyrat C; Allenet B; Bouzige B; Develay A; Fraysse M; Garnier V; Halimi JM; Roux-Marson C; Giraudeau B
    Br J Clin Pharmacol; 2020 Dec; 86(12):2441-2454. PubMed ID: 32383801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a trAnSitional Pharmacist Intervention in geRiatric inpatients on hospital visits after dischargE (ASPIRE): Protocol for a randomized controlled trial.
    Hias J; Hellemans L; Laenen A; Walgraeve K; Liesenborghs A; De Geest S; Luyten J; Spriet I; Flamaing J; Van der Linden L; Tournoy J
    Contemp Clin Trials; 2022 Aug; 119():106853. PubMed ID: 35842106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A stepped wedge trial of efficacy and scalability of a virtual clinical pharmacy service (VCPS) in rural and remote NSW health facilities.
    Allan J; Nott S; Chambers B; Hawthorn G; Munro A; Doran C; Oldmeadow C; Coleman C; Saksena T
    BMC Health Serv Res; 2020 May; 20(1):373. PubMed ID: 32366308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.